NCT06787183View on ClinicalTrials.gov

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Locally Advanced Rectal Cancer With Liver Metastases
Interventions
RADIATION

Short course radiotherapy

CTV 25Gy/5Fx.

DRUG

Capecitabine

1000mg/m2, d1-14，bid, q3w, 2 cycles.

DRUG

Oxaliplatin

130mg/m2, d1, q3w, 2 cycles

DRUG

QL1706

5.0 mg/kg, q3w

Trial Locations (1)

350014

Fujian Cancer Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Cancer Hospital

OTHER_GOV